A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Lambert, Allison A ^a   Kirk, Gregory D ^a,b   Astemborski, Jacquie ^b   Neptune, Enid R ^a   Mehta, Shruti H ^b   Wise, Robert A ^a   Drummond, M Bradley ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CATHELICIDIN; 25-HYDROXYVITAMIN D; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; VITAMIN D;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BACTERIAL PNEUMONIA; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PREVALENCE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK FACTOR; SMOKING HABIT; SPIROMETRY; URBAN POPULATION; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SMOKING; VITAMIN D DEFICIENCY;

ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HIV INFECTIONS; HUMANS; LUNG; MALE; MIDDLE AGED; SMOKING; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84899671206     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095099     Document Type: Article

References (43)

1. National Institutes of Health; National Heart LaBI Morbidity & Mortality (2012) 2012 Chart Book on Cardiovascular, Lung and Blood Diseases.
2. Mannino DM, Buist AS (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370: 765-773. (Pubitemid 47321908)
3. To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, et al. (2012) Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC public health 12: 204.
4. Ketelaars CA, Schlosser MA, Mostert R, Huyer-Abu-Saad H, Halfens RJ, et al. (1996) Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax 51: 39-43. (Pubitemid 26048724)
5. Wise RA (2006) The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression. The American journal of medicine 119: 4-11. (Pubitemid 44402279)
6. Morris AM, Huang L, Bacchetti P, Turner J, Hopewell PC, et al. (2000) Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. American journal of respiratory and critical care medicine 162: 612-616. (Pubitemid 30647208)
7. Chalmers JD, McHugh BJ, Docherty C, Govan JR, Hill AT (2013) Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis. Thorax 68: 39-47.
8. Black PN, Scragg R (2005) Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 128: 3792-3798. (Pubitemid 43062638)
9. Schauber J, Dorschner RA, Coda AB, Buchau AS, Liu PT, et al. (2007) Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. The Journal of clinical investigation 117: 803-811. (Pubitemid 46348539)
10. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
11. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, et al. (2004) Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. Journal of immunology 173: 2909-2912. (Pubitemid 39141992)
12. Ramanathan B, Davis EG, Ross CR, Blecha F (2002) Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes and infection/Institut Pasteur 4: 361-372. (Pubitemid 34293642)
13. Barlow PG, Findlay EG, Currie SM, Davidson DJ (2014) Antiviral potential of cathelicidins. Future microbiology 9: 55-73.
14. De Y, Chen Q, Schmidt AP, Anderson GM, Wang JM, et al. (2000) LL-37, the neutrophil granule- And epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. The Journal of experimental medicine 192: 1069-1074.
15. Vlahov D, Anthony JC, Munoz A, Margolick J, Nelson KE, et al. (1991) The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA research monograph 109: 75-100. (Pubitemid 23095616)
16. Marshall MM, Kirk GD, Caporaso NE, McCormack MC, Merlo CA, et al. (2011) Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addictive behaviors 36: 61-67.
17. Drummond MB, Kirk GD, Astemborski J, McCormack MC, Marshall MM, et al. (2011) Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users. International journal of chronic obstructive pulmonary disease 6: 89-95.
18. Estrella MM, Kirk GD, Mehta SH, Brown TT, Fine DM, et al. (2012) Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users. Aids 26: 295-302.
19. Drummond MB, Kirk GD, Astemborski J, Marshall MM, Mehta SH, et al. (2012) Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax 67: 309-314.
20. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013.
21. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. The Journal of clinical endocrinology and metabolism 96: 1911-1930.
22. Golec M, Reichel C, Mackiewicz B, Skorska C, Curzytek K, et al. (2009) Cathelicidin LL-37, granzymes, TGF-beta1 and cytokines levels in induced sputum from farmers with and without COPD. Annals of agricultural and environmental medicine: AAEM 16: 289-297.
23. Jiang YY, Xiao W, Zhu MX, Yang ZH, Pan XJ, et al. (2012) The effect of human antibacterial peptide LL-37 in the pathogenesis of chronic obstructive pulmonary disease. Respiratory medicine 106: 1680-1689.
24. Chen CI, Schaller-Bals S, Paul KP, Wahn U, Bals R (2004) Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society 3: 45-50. (Pubitemid 38397023)
25. Liu MC, Xiao HQ, Brown AJ, Ritter CS, Schroeder J (2012) Association of vitamin D and antimicrobial peptide production during late-phase allergic responses in the lung. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology 42: 383-391.
26. Parameswaran GI, Sethi S, Murphy TF (2011) Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD. Chest 140: 611-617.
27. Bals R, Wang X, Zasloff M, Wilson JM (1998) The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proceedings of the National Academy of Sciences of the United States of America 95: 9541-9546. (Pubitemid 28506267)
28. Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, et al. (2011) Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PloS one 6: e25333.
29. Mansbach JM, Piedra PA, Borregaard N, Martineau AR, Neuman MI, et al. (2012) Serum cathelicidin level is associated with viral etiology and severity of bronchiolitis. The Journal of allergy and clinical immunology 130: 1007-1008 e1001.
30. Kovach MA, Ballinger MN, Newstead MW, Zeng X, Bhan U, et al. (2012) Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia. Journal of immunology 189: 304-311.
31. Liu PT, Stenger S, Tang DH, Modlin RL (2007) Cutting edge: vitamin Dmediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. Journal of immunology 179: 2060- 2063.
32. Barlow PG, Beaumont PE, Cosseau C, Mackellar A, Wilkinson TS, et al. (2010) The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium. American journal of respiratory cell and molecular biology 43: 692-702.
33. Evans SA, Turner SM, Bosch BJ, Hardy CC, Woodhead MA (1996) Lung function in bronchiectasis: The influence of Pseudomonas aeruginosa. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology 9: 1601-1604. (Pubitemid 26271139)
34. Agerberth B, Charo J, Werr J, Olsson B, Idali F, et al. (2000) The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96: 3086- 3093.
35. Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sorensen OE, et al. (2003) The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. Journal of immunology 171: 6690-6696. (Pubitemid 37532101)
36. Levinson P, Choi RY, Cole AL, Hirbod T, Rhedin S, et al. (2012) HIVneutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships. PloS one 7: e31996.
37. Levinson P, Kaul R, Kimani J, Ngugi E, Moses S, et al. (2009) Levels of innate immune factors in genital fluids: Association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. Aids 23: 309-317.
38. Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, et al. (2010) Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 65: 215-220.
39. Berry DJ, Hesketh K, Power C, Hypponen E (2011) Vitamin D status has a linear association with seasonal infections and lung function in British adults. The British journal of nutrition 106: 1433-1440.
40. Tolppanen AM, Williams D, Henderson J, Lawlor DA (2011) Serum 25- hydroxy-vitamin D and ionised calcium in relation to lung function and allergen skin tests. European journal of clinical nutrition 65: 493-500.
41. Lange NE, Sparrow D, Vokonas P, Litonjua AA (2012) Vitamin D deficiency, smoking, and lung function in the Normative Aging Study. American journal of respiratory and critical care medicine 186: 616-621.
42. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, et al. (2008) Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. Journal of immunology 181: 7090-7099.
43. Hata TR, Kotol P, Jackson M, Nguyen M, Paik A, et al. (2008) Administration of oral vitamin D induces cathelicidin production in atopic individuals. The Journal of allergy and clinical immunology 122: 829-831.